Oddity Tech Stock ODD
ODDITY Tech is a consumer technology company that builds and operates direct-to-consumer beauty and wellness brands, generating revenue primarily through online product sales to end consumers. Oddity Tech stock (ODD): Quarterly and annual results since 2023 from Quarterly Report and SEC filings: revenue, earnings, balance sheet, cash flow and management guidance, every figure with its source. As of 09/2026, quarterly reporting. Stock analysis by NadirAlpha. Oddity Tech stock (ODD): listed on Nasdaq. NadirAlpha has evaluated 27 original documents, cross-checked every figure automatically and linked each to its source; sources as of 09/2026. Revenue Q2 2026: USD 180 million (-25% year on year). Latest reading: Net income halved, Revenue decelerating, Margin compressing, Guidance confirmed.
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
Oddity Tech Current Status
The current state of Oddity Tech at a glance, figures as of Q2 2026, with core figures and the key management statements from the latest filing. NadirAlpha methodology
Assessment by NadirAlpha, as of Q2 2026.
“We made progress during the quarter, including strong results for both SpoiledChild and METHODIQ. We remain hopeful that IL MAKIAGE is on track to achieve normalization and we continue to work in close partnership with our largest advertising partner to solve the technical issue.”
“So far in the third quarter, we are seeing an improved year-over-year net revenue trend, driven by growth at SpoiledChild and METHODIQ and a moderating impact from the IL MAKIAGE account dislocation. As a result, we now expect third quarter net revenue to decline approximately 5% year-over-year, a meaningful sequential improvement from the first half.”
Oddity Tech Stock: Key Figures ($ million)
Revenue, margin, earnings and EPS of Oddity Tech per fiscal year, half-year and quarter in $ million, as of Q2 2026, as reported in the filing; restatements show the most recent filing version. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Fiscal years
| Period | Revenue | Op. income | Op. income (adj.) | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | OCF | Source |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | 809.8 | 118.8 | 152.66 | 110.7 | 1.80 | 2.21 | 163.35 | 87.6 | 24 |
| FY2024 | 647 | 115.6 | 140.62 | 101.5 | 1.64 | 1.96 | 150.45 | 137.8 | 15 |
| FY2023 | 508.7 | 74.3 | 98.73 | 58.5 | 1.00 | 1.31 | 107.33 | 87.5 | 7 |
Quarters
| Period | Published | Revenue | Op. income | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | FCF | Cash | Net Debt | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q2* | 2026-09-09 | 180.5 | – | 12.9 | 0.21*≈ | 0.20 | 12.9 | 13.6 | 167.3 | – | 127 |
| 2026-Q1* | 2026-06-02 | 197.9 | – | -21.4 | -0.35*≈ | -0.17 | -7 | -21.1 | 278.6 | – | 125 |
| 2025-Q4* | 2026-02-25 | 152.7 | 1.7 | 5.9 | 0.10 | 0.20 | 12.5 | -5.9 | 402.2 | 182.2 | 122 |
| 2025-Q3* | 2025-11-19 | 147.9 | 17.4 | 17.7 | 0.28 | 0.40 | 28.9 | -9.9 | 592 | – | 121 |
| 2025-Q2* | 2025-08-04 | 241.1 | 57.1 | 49.3 | 0.79 | 0.92 | 69.5 | 12.1 | 656.8 | – | 18 |
| 2025-Q1* | 2025-04-29 | 268.1 | 42.7 | 37.8 | 0.63 | 0.69 | 52.4 | 87.3 | 136.9 | – | 16 |
| 2024-Q4* | 2025-02-25 | 123.6 | 4 | 5.3 | 0.09 | 0.20 | 15.2 | 15.3 | 50.3 | – | 14 |
| 2024-Q3* | 2024-11-06 | 119 | 19.5 | 17.7 | 0.29 | 0.32 | 24.8 | 15.3 | 85.9 | – | 12 |
| 2024-Q2* | 2024-08-07 | 192.8 | 53 | 45.5 | 0.73 | 0.82 | 62.3 | 24.9 | 86.9 | – | 10 |
| 2024-Q1* | 2024-05-07 | 211.6 | 39 | 33 | 0.53 | 0.61 | 48.1 | 79 | – | – | 8 |
| 2023-Q4* | 2024-03-05 | 97.2 | 6.5 | 5.1 | 0.08 | 0.17 | 16.3 | 7.4 | 36.5 | – | 6 |
| 2023-Q3* | 2023-10-02 | 94.5 | 6.3 | 3.8 | 0.06 | 0.21 | 20.8 | 2.8 | 63.9 | – | 4 |
| 2023-Q2* | 2023-08-09 | 151.3 | 36.8 | 30 | 0.52 | 0.56 | 41.8 | – | 66.5 | – | 1 |
| 2023-Q1* | 2024-05-07 | 165.7 | 24.7 | 19.6 | 0.35 | 0.37 | 28.4 | – | – | – | 108 |
Oddity Tech Balance Sheet & Cash Flow ($ million)
NadirAlpha places cash, debt, operating cash flow and investments of Oddity Tech side by side per period, balance sheet values as of the period end, flow items for the period. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
Fiscal years
| Period | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | 2026-02-25 | 402.2 | 584.4 | 182.2 | 10.7 | 87.6 | 3.9 | 83.6 | 22 |
| FY2024 | 2025-02-25 | 50.3 | – | – | 9.8 | 137.8 | 3.3 | 134.5 | 15 |
| FY2023 | 2024-03-05 | 36.5 | – | – | 8.6 | 87.5 | 2.1 | 85.4 | 6 |
Quarters
| Period | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q2 | 2026-09-09 | 167.3 | – | – | 3.2 | 14.3 | 0.7 | 13.6 | 127 |
| 2026-Q1 | 2026-06-02 | 278.6 | – | – | 4.3 | -20.2 | 0.9 | -21.1 | 125 |
| 2025-Q4 | 2026-02-25 | 402.2 | 584.4 | 182.2 | 2.7 | -5 | 1 | -5.9 | 122 |
| 2025-Q3 | 2025-11-19 | 592 | – | – | 2.7 | -8.8 | 1 | -9.9 | 121 |
| 2025-Q2 | 2025-08-04 | 656.8 | – | – | 2.7 | 13 | 0.9 | 12.1 | 18 |
| 2025-Q1 | 2025-04-29 | 136.9 | – | – | 2.7 | 88.3 | 1 | 87.3 | 16 |
| 2024-Q4 | 2025-02-25 | 50.3 | – | – | 2.7 | 16.2 | 0.9 | 15.3 | 14 |
| 2024-Q3 | 2024-11-06 | 85.9 | – | – | 2.6 | 16.2 | 0.9 | 15.3 | 12 |
| 2024-Q2 | 2024-08-07 | 86.9 | – | – | 2.3 | 25.8 | 0.8 | 24.9 | 10 |
| 2024-Q1 | 2024-05-07 | – | – | – | 2.3 | 79.6 | 0.7 | 79 | 8 |
| 2023-Q4 | 2024-03-05 | 36.5 | – | – | 2.4 | 7.9 | 0.5 | 7.4 | 6 |
| 2023-Q3 | 2023-11-07 | 63.9 | – | – | 2.2 | 3.6 | 0.8 | 2.8 | 5 |
| 2023-Q2 | 2023-08-09 | 66.5 | – | – | 2.1 | 22.8 | – | – | 1 |
| 2023-Q1 | 2024-05-07 | – | – | – | 1.9 | 53.2 | – | – | 108 |
Oddity Tech Guidance Tracking (latest per metric/period · 26/59)
NadirAlpha records 59 guidance statements of Oddity Tech neutrally: annual and quarterly targets, direction of change and outcome as a dot with legend, with no estimate of our own. NadirAlpha methodology
Actuals: revenue in $m · EPS in $ per share · ratios in %
Direction: confirmedcutinitiatedraised Verdict: beatmisspending
| For period | Guided on | Metric | Guided | Actual | Verdict | Direction | Source |
|---|---|---|---|---|---|---|---|
| FY2026 | 2026-09-09 | EBITDA (Adjusted) | 30–32 | – | 27 | ||
| FY2026 | 2026-09-09 | Revenue growth (YoY) | ~19% | – | 27 | ||
| 2026-Q3 | 2026-09-09 | EBITDA (Adjusted) | 18–20 | – | 27 | ||
| 2026-Q3 | 2026-09-09 | Revenue growth (YoY) | ~5% | – | 27 | ||
| 2026-Q2 | 2026-06-02 | EBITDA (Adjusted) | 8–10 | 12.9 | 25 | ||
| 2026-Q2 | 2026-06-02 | Revenue growth (YoY) | 25–30% | -25.1 | 25 | ||
| 2026-Q1 | 2026-02-25 | Revenue growth (YoY) | ~30% | -26.2 | 22 | ||
| FY2025 | 2025-11-19 | Revenue | 806–809 | 809.8 | 21 | ||
| FY2025 | 2025-11-19 | Gross margin (GAAP) | ~72.5% | – | – | 21 | |
| FY2025 | 2025-11-19 | EPS (non-GAAP) | 2.1–2.12 | 2.21 | 21 | ||
| FY2025 | 2025-11-19 | EBITDA (Adjusted) | 161–163 | 163.35 | 21 | ||
| 2025-Q4 | 2025-11-19 | Revenue | 149–152 | 152.7 | 21 | ||
| 2025-Q4 | 2025-11-19 | EPS (non-GAAP) | 0.11–0.13 | 0.2 | 21 | ||
| 2025-Q4 | 2025-11-19 | EBITDA (Adjusted) | 10–12 | 12.5 | 21 | ||
| 2025-Q3 | 2025-08-04 | Revenue | 144–146 | 147.9 | 18 | ||
| 2025-Q3 | 2025-08-04 | Gross margin (GAAP) | 68% | – | – | 18 | |
| 2025-Q3 | 2025-08-04 | EPS (non-GAAP) | 0.33–0.36 | 0.4 | 18 | ||
| 2025-Q3 | 2025-08-04 | EBITDA (Adjusted) | 26–28 | 28.9 | 18 | ||
| 2025-Q2 | 2025-04-29 | Revenue | 235–239 | 241.1 | 16 | ||
| 2025-Q2 | 2025-04-29 | Gross margin (GAAP) | 70.5% | – | – | 16 | |
| 2025-Q2 | 2025-04-29 | EPS (non-GAAP) | 0.85–0.89 | 0.92 | 16 | ||
| 2025-Q2 | 2025-04-29 | EBITDA (Adjusted) | 65–68 | 69.5 | 16 | ||
| 2025-Q1 | 2025-02-25 | Revenue | 258–262 | 268.1 | 14 | ||
| 2025-Q1 | 2025-02-25 | Gross margin (GAAP) | ~72% | – | – | 14 | |
| 2025-Q1 | 2025-02-25 | EPS (non-GAAP) | 0.61–0.63 | 0.69 | 14 | ||
| 2025-Q1 | 2025-02-25 | EBITDA (Adjusted) | 49–50 | 52.4 | 14 | ||
| FY2024 | 2024-11-06 | Revenue | 642–644 | 647 | 12 | ||
| FY2024 | 2024-11-06 | Gross margin (GAAP) | 71.5% | – | – | 12 | |
| FY2024 | 2024-11-06 | EPS (non-GAAP) | 1.85–1.87 | 1.96 | 12 | ||
| FY2024 | 2024-11-06 | EBITDA (Adjusted) | 147–149 | 150.45 | 12 | ||
| 2024-Q4 | 2024-11-06 | Revenue | 118–120 | 123.6 | 12 | ||
| 2024-Q4 | 2024-11-06 | EPS (non-GAAP) | 0.11–0.13 | 0.2 | 12 | ||
| 2024-Q4 | 2024-11-06 | EBITDA (Adjusted) | 12–14 | 15.2 | 12 | ||
| 2024-Q3 | 2024-08-07 | Revenue | 115–117 | 119 | 10 | ||
| 2024-Q3 | 2024-08-07 | Gross margin (GAAP) | 68% | – | – | 10 | |
| 2024-Q3 | 2024-08-07 | EPS (non-GAAP) | 0.21–0.23 | 0.32 | 10 | ||
| 2024-Q3 | 2024-08-07 | EBITDA (Adjusted) | 21–23 | 24.8 | 10 | ||
| 2024-Q2 | 2024-06-07 | EPS (non-GAAP) | exceeding the range | 0.82 | – | 9 | |
| 2024-Q2 | 2024-06-07 | EBITDA (Adjusted) | exceeding the range | 62.3 | – | 9 | |
| 2024-Q2 | 2024-05-07 | Revenue | 185–189 | 192.8 | 9 | ||
| 2024-Q2 | 2024-05-07 | Gross margin (GAAP) | 71% | – | – | 8 | |
| 2024-Q1 | 2024-03-05 | Revenue | 204–207 | 211.6 | 6 | ||
| 2024-Q1 | 2024-03-05 | Gross margin (GAAP) | 71% | – | – | 6 | |
| 2024-Q1 | 2024-03-05 | EPS (non-GAAP) | 0.47–0.5 | 0.61 | 6 | ||
| 2024-Q1 | 2024-03-05 | EBITDA (Adjusted) | 43–45 | 48.1 | 6 | ||
| FY2023 | 2023-11-07 | Revenue | 493–497 | 508.7 | 5 | ||
| FY2023 | 2023-11-07 | Gross margin (GAAP) | 70% | – | – | 5 | |
| FY2023 | 2023-11-07 | EPS (non-GAAP) | 1.21–1.23 | 1.31 | 5 | ||
| FY2023 | 2023-11-07 | EBITDA (Adjusted) | 104–105 | 107.33 | 5 | ||
| 2023-Q4 | 2023-11-07 | Revenue | 82–85 | 97.2 | 5 | ||
| 2023-Q4 | 2023-11-07 | Gross margin (GAAP) | 66% | – | – | 5 | |
| 2023-Q4 | 2023-11-07 | EPS (non-GAAP) | 0.1–0.12 | 0.17 | 5 | ||
| 2023-Q4 | 2023-11-07 | EBITDA (Adjusted) | 13–14 | 16.3 | 5 | ||
| 2023-Q3 | 2023-10-02 ° | EBITDA margin | 21–21.5% | 9 | 4 | ||
| 2023-Q3 | 2023-10-02 ° | Revenue growth (YoY) | 29–31% | 37.2 | 4 | ||
| 2023-Q3 | 2023-08-09 | Revenue | 81–85 | 94.5 | 1 | ||
| 2023-Q3 | 2023-08-09 | Gross margin (GAAP) | ~67.5% | – | – | 1 | |
| 2023-Q3 | 2023-08-09 | EPS (non-GAAP) | 0.13–0.15 | 0.21 | 1 | ||
| 2023-Q3 | 2023-08-09 | EBITDA (Adjusted) | 16–18 | 20.8 | 1 |
Oddity Tech Stock: Price & Chart
Chart and key figure trend of Oddity Tech stock: the TradingView chart starts only on click, the key figure chart comes from the core tables up to Q2 2026. NadirAlpha methodology
Daily candles with news and earnings markers. Loads only on click.
Oddity Tech Event Timeline
What happened at Oddity Tech since 2023: events from the filings, grouped by quarter, with the source date and a clickable source number. NadirAlpha methodology
2026 · 7 events
Net revenue declined 25% year-over-year to 180.5 million as IL MAKIAGE continued to face advertising account dislocation 27
Gross margin contracted 350 basis points to 68.7%; gross profit declined 29% year-over-year to $124 million 27
Full year 2026 guidance set at net revenue declining approximately 19% year-over-year and adjusted EBITDA between $30 million and $32 million 27
“We continue to implement our recovery plan to address the account dislocation with our largest advertising partner and we remain hopeful that we are on track for normalization in the second half of this year. For many years, our CPA was very stable, with only gradual increases aligned with our industry. In Q1 2026, we saw a severe step-function discontinuity, comparing to historical first quarters, with CPA in some cases reaching levels 2x higher than what we expected. While we continue to navigate this dislocation, we have been working closely with our advertising partner on remediation and we are encouraged by an improvement in IL MAKIAGE CPA this May, which declined an estimated -28% sequentially from April.”
Adjusted EBITDA swung from $52.4 million profit to a $7.0 million loss, driven by higher customer acquisition costs and remediation spending 25
Net revenue declined 26% year-over-year to 197.9 million due to customer acquisition cost dislocation with IL MAKIAGE's largest advertising partner 25
Gross margin compressed 520 basis points to 69.7% due to product and brand mix, lower average order value, and remediation testing 25
2025 · 11 events
“ODDITY delivered strong fourth quarter results to cap off a record breaking 2025, once again exceeding our guidance across revenue, profit, and earnings per share like we did in the past 11 consecutive quarters since going public. The strength of our business, reflected in strong sales from repeat customers, allowed us to deliver excellent financial results, with double digit revenue growth from both IL MAKIAGE and SpoiledChild. We also continued to invest in our future growth drivers, including a successful launch of our 3rd brand METHODIQ during the fourth quarter with strong early signs.”
Q4 gross margin declined 220 basis points to 70.5% and full-year gross margin declined 50 basis points to 72.7% 22
Net debt of 182.2 million at year-end, reflecting $600 million notes issuance in June 2025; company had zero outstanding debt entering 2025 22
Q1 2026 net revenue expected to decline approximately 30% year-over-year due to significant dislocation in customer acquisition costs from algorithmic changes at the largest advertising partner 22
Operating income more than halved YoY (4.0 to USD 1.7 million, -57%). 122
“ODDITY delivered strong third quarter results, including financial performance that once again exceeded our guidance across revenue, profit, and earnings per share. We are well positioned for a strong finish in 2025 with multiple engines to drive future growth, and we continue to invest in new brands, ODDITY Labs, and tech innovation.”
Gross margin expanded 170 basis points to 71.6% in Q3 from 69.9% in the prior year quarter 21
Full-year 2025 net revenue guidance raised to $806-809 million and gross margin guidance raised to approximately 72.5% 21
METHODIQ, third brand launched in November 2025, aims to transform medical care with precise treatments and technology 21
“These strong financials allow us to continue reinvesting in our future, including technology, ODDITY Labs, and building new brands”
Net revenue of 241.1 million, up 25% year-over-year, with double-digit growth for both IL MAKIAGE and SpoiledChild 18
Full-year 2025 net revenue guidance raised to $799-804 million and adjusted EBITDA guidance raised to $160-162 million 18
“Our early and aggressive investments in this transformation allow us to sustain a powerful financial model, to beat our guidance, and to once again raise our full year outlook as we have done in the past 8 quarters since our IPO. Our DNA, business model, and strong performance allow us to play full offense in times like today.”
Net revenue of 268.1 million, up 27% year-over-year, exceeded guidance across all metrics 16
Full-year 2025 net revenue guidance raised to $790-798 million following first-quarter outperformance 16
2024 · 15 events
“Our brands today continue to deliver strong and profitable growth, while we build powerful engines for our future with new technology products, ODDITY LABS, and our new brands.”
Exceeded financial guidance across every metric for the fourth quarter and full year 2024 14
2025 net revenue guided at $776-785 million, representing approximately 20% growth at the midpoint 14
“The beauty industry is transforming, and we believe ODDITY is leading this transformation. Our outstanding third quarter results demonstrate once again how our investments in the two most important vectors of industry growth, consumer demand for online and for high performance products, are driving outsized, profitable growth, market share gains, and powerful cash flows.”
Gross margin declined 35 basis points to 69.9% and adjusted EBITDA margin declined 112 basis points to 20.9% in Q3 2024 12
Exceeded Q3 2024 financial guidance across every metric and raised full-year 2024 outlook 12
Operating income more than doubled YoY (6.3 to USD 19.5 million, +210%). 121
“We are grateful to Evan for creating a strong foundation for ODDITY LABS following our acquisition of Revela, the company he had co-founded. He is a talented scientist and entrepreneur, and we wish him the best in the future.”
Full-year 2024 net revenue guidance raised to $633-640 million, representing 24-26% year-over-year growth 10
“We delivered our most important quarter of the year with outstanding revenue growth and profitability. We delivered across all metrics and grew rapidly against the huge and profitable 83% revenue growth we delivered in the first quarter of 2023. Despite market speculation about an industry slowdown, we haven't seen any slowdown in our platform, not in new users and not in existing users behavior.”
Full-year 2024 outlook for net revenue, adjusted EBITDA, and adjusted diluted EPS raised 8
2023 · 10 events
“Our large investments in technology and product over the past 5 years are yielding significant returns and allow the rare combination of scale, growth, and profitability.”
Gross margin expanded to 70.4% from 67.2% in the prior year, largely driven by supply chain efficiencies; full year adjusted EBITDA reached $107.3 million at a 21% adjusted EBITDA margin 7
Full year net revenue reached 508.7 million, up 57% year-over-year, crossing the $500 million milestone 6
ODDITY announced Brand 3, a medical-grade skin and body brand, and Brand 4 for planned launch in 2025, with the platform reaching 50 million users 6
“Our third quarter is our best third quarter ever, exceeding our guidance. We delivered net revenue growth of 60% and adjusted EBITDA of $91 million in the first nine months of 2023, and are increasing our sales and profit outlook for the full year. We continue to deliver excellent growth and profitability for IL MAKIAGE and SpoiledChild, while building powerful engines to scale our business and expand our lead in 2024 and beyond. Our business continues to fire on all cylinders and is the strongest it has ever been. Our large investments in technology and data capabilities over the past five years are enabling us to continue to grow fast without damaging our high margins and strong profitability.”
“Our third quarter is expected to be our strongest third quarter ever, exceeding our guidance and allowing us to deliver net revenue growth of at least 58% and adjusted EBITDA of at least $89 million in the first three quarters of 2023. These strong financial results reflect the power of our platform, built to transform the global beauty and wellness market through technology and data usage. We continue to consistently deliver high growth and outstanding profitability with both IL MAKIAGE and SpoiledChild brands and are building massive engines to further scale in 2024 and beyond. ODDITY LABS, powered by the Revela biotech integration, is expanding its molecule discovery platform faster than expected, and is delivering game changing ingredient innovation to support continued high growth for IL MAKIAGE, SpoiledChild, and our new brands in development.”
ODDITY completed its initial public offering on Nasdaq on July 19, 2023, issuing 1,754,385 Class A ordinary shares at $35.00 per share with net proceeds of $50.3 million 7
Full year 2023 net revenue guidance raised to $493-497 million and adjusted EBITDA guidance raised to $104-105 million 5
Q3 net revenue grew 29-31% year-over-year, exceeding initial guidance of 18-23% growth, with gross margin approximately 100 basis points above initial guidance 4
“We are unlocking online for this massive, global TAM by leveraging data science, artificial intelligence, and computer vision to deliver superior products and experiences to our over 40 million users.”
ODDITY acquired Revela Inc. for total consideration of $67.4 million and established ODDITY LABS as an AI-based molecule discovery platform for beauty and wellness 7
Q2 net revenue of 151.3 million represented 55% year-over-year growth, exceeding preliminary estimates by $11.8 million 1
Full year 2023 net revenue guidance raised to $475-480 million from a prior 40% growth expectation; adjusted diluted EPS guidance raised to $1.11-1.17 from $1.06 1
Oddity Tech Business Model
The Oddity Tech business model in brief: products, customers and revenue sources as the company itself describes them in its reports. NadirAlpha methodology
ODDITY Tech is a consumer technology company that builds and operates direct-to-consumer beauty and wellness brands, generating revenue primarily through online product sales to end consumers. Its core brand, IL MAKIAGE, offers makeup and skin care products through an AI-driven platform that personalizes the shopping and product-matching experience; SpoiledChild addresses hair and skin care, while METHODIQ targets the professional wellness segment. Customer acquisition and retention are supported by the company's proprietary technology stack and data science capabilities, and ODDITY Labs functions as an internal molecule discovery platform aimed at developing proprietary compounds for use across the brand portfolio.
Oddity Tech Stock: Share-Price Drivers
What determines the business trajectory of Oddity Tech according to management, summarised from the reports up to Q2 2026. NadirAlpha methodology
ODDITY generates almost all of its revenue through its online direct-to-consumer channel, so the quarterly revenue trajectory drives the business; revenue was 180.5 million in 2026-Q2, lower than 197.9 million in the prior quarter and 241.1 million a year earlier, with net income of 12.9 million 127.
ODDITY's online direct-to-consumer channel supplies nearly all reported revenue; revenue of 180.5 million in 2026-Q2 was below 241.1 million a year earlier, and growth has been decelerating 27 127.
ODDITY moved Brand 3 from a soft launch to a formal launch during 2025 and continues to develop Brand 4, so traction of these additional brands is still building and not yet proven at scale 16 24.
ODDITY launched the METHODIQ medical telehealth platform in 2025 and continued to roll out SpoiledChild, extending the brand portfolio into adjacent beauty and wellness categories 24 27.
ODDITY continues to scale its ODDITY LABS molecule discovery platform as a source of proprietary ingredients, with the contribution to products still developing 27.
ODDITY authorised a Class A ordinary share repurchase program and repurchased 0% exchangeable notes due 2030, while holding cash of 167.3 million at 2026-Q2 25 27.
Sector trend: ODDITY reported that revenue growth in its online beauty and wellness channel is decelerating and that guidance was cut, pointing to softer demand momentum relative to prior quarters 127. Operating income and net income have been uneven across recent quarters, indicating margin pressure alongside the slower top-line trend 127.
Oddity Tech Revenue by Type (as of 2026-Q2 · USD million · 2/4)
The segments of Oddity Tech in the company's own definition, each row with its basis (3, 6 or 12 months), rows in grey are no longer reported separately. NadirAlpha methodology
| Segment | Since | Revenue | Growth | Margin | Source |
|---|---|---|---|---|---|
| Period 2026-Q2 (6M) | |||||
| Online direct-to-consumer | 2023-Q3 | 367.1 | – | 97% | 27 |
| Other (Israel retail, marketing affiliates) | 2023-Q3 | 11.3 | – | 3% | 27 |
| Period FY2023 (12M) | |||||
| United States | FY2023 | 0.4 | 71.7% | – | 7 |
| Other Geographies | FY2023 | 0.1 | 13.4% | – | 7 |
Oddity Tech Products & announcements (7/17 active+recent)
What Oddity Tech launched, had approved or announced, from the filings up to Q2 2026, each row with the date of first mention. NadirAlpha methodology
Status: LaunchedPlanned
| Product/Line | Since | Status | Source |
|---|---|---|---|
| 2026 | |||
| SpoiledChild | 2026-06 | 27 | |
| 2025 | |||
| METHODIQ | 2025-11 | 27 | |
| METHODIQ medical telehealth platform launch | 2025 | 24 | |
| 2024 | |||
| Brand 3 Medical-grade Skin and Body Brand Launch (2×) | 2024-12 | 6 | |
| Brand 4 development (4×) | 2024-06 | 24 | |
| ODDITY Labs molecule discovery platform (4×) | 2024-03 | 27 | |
| 2022 | |||
| Brand 3 launch (6×) | 2022 | 18 | |
| 2024 | |||
| Brand 4 - New brand to lead in an attractive beauty and wellness category | 2024-12 | 14 | |
| Continued development of brands 3 and 4 to disrupt additional large beauty and wellness categories | 2024-03 | 8 | |
| 2024 Facility Agreements | 2024-01 | 7 | |
| 2023 | |||
| Forward share split 15.396-for-1 | 2023-07 | 7 | |
| Digital Securities conversion to Class A Ordinary shares | 2023-07 | 7 | |
| Launch of ODDITY LABS | 2023-06 | 1 | |
| $100 million Credit Facility | 2023 | 6 | |
| 2020 | |||
| Expansion to continental Europe and Australia | 2020 | 15 | |
| Expansion to U.K. market | 2020 | 15 | |
| 2018 | |||
| IL MAKIAGE launch in United States | 2018 | 15 | |
Oddity Tech Transactions & Events (6)
All recorded acquisitions, divestitures and exits of Oddity Tech, plus partnerships, contracts and regulatory events affecting the business, each with date and source. NadirAlpha methodology
Acquisitions by Oddity Tech
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2023 | |||
| ODDITY LABS establishment | 2023-04 | Completed | 7 |
| Revela acquisition | 2023 | Completed | 24 |
| Revela Acquisition and Integration | 2023 | Completed | 6 |
| Acquisition of Revela and establishment of ODDITY LABS | 2023 | Completed | 15 |
| 2021 | |||
| Voyage81 acquisition | 2021 | Completed | 24 |
Divestitures and exits by Oddity Tech
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2026 | |||
| Registration Rights Termination | 2026-07 | Divested | 15 |
Oddity Tech Risks (169 since the annual report of 2026-03-17, 365 tracked in total)
NadirAlpha lists 169 active risks of Oddity Tech from the filings, the category as a coloured dot with legend, the wording as a short summary of the filing with no assessment of our own. NadirAlpha methodology
Category: CustomersFinancialTechnologyMarketPeopleRegulatoryGeopoliticsLegalSupply chainMacroStrategyCompetitionCyberESGlogistik
| Risk | Category | Last reported |
|---|---|---|
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2026-09-09 (2026-Q2), source 27 | ||
| IL MAKIAGE advertising algorithm dislocation impacting largest customer revenue. | = | |
| Exposure to trade restrictions, existing and potential tariffs. | = | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2026-06-02 (2026-Q1), source 25 | ||
| Dependence on advertising platform algorithms for customer acquisition; technical disruptions impact sales. | 2026-Q2 2026-09-09 27 | |
| Oddity Tech: first mention in 20-F annual report of 2025-02-25 (FY2024), source 15 | ||
| Ability to anticipate and respond to changes in consumer preferences and market trends. | 2026-Q2 2026-09-09 27 | |
| Oddity Tech: first mention in 20-F annual report of 2024-03-06 (FY2023), source 7 | ||
| Ability to cost-effectively attract new customers and respond to algorithm-based bidding system changes. | 2026-Q2 2026-09-09 27 | |
| Dependence on executive leadership and ability to retain key personnel. | 2026-Q2 2026-09-09 27 | |
| Compliance with data privacy and security laws; risks from data breaches and cyberattacks. | 2026-Q2 2026-09-09 27 | |
| Compliance with evolving laws and regulations applicable to internet, e-commerce, and AI-related activities. | 2026-Q2 2026-09-09 27 | |
| Ability to comply with changing tax laws and anti-corruption regulations. | 2026-Q2 2026-09-09 27 | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2024-03-05 (2023-Q4), source 6 | ||
| Business operations exposed to geopolitical conditions in Israel and the Middle East conflict. | 2026-Q2 2026-09-09 27 | |
| Failure of products to comply with quality standards and product liability claims. | 2026-Q2 2026-09-09 27 | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2023-10-02 (2023-Q3), source 4 | ||
| Exposure to foreign currency fluctuations. | 2026-Q2 2026-09-09 27 | |
| Risk of supplier loss or disruptions in supply of raw materials and finished products. | 2026-Q2 2026-09-09 27 | |
| Vulnerability to general economic downturn or sudden business condition disruptions. | 2026-Q2 2026-09-09 27 | |
| Illegal distribution and sale of counterfeit products and unauthorized product diversion. | 2026-Q2 2026-09-09 27 | |
| Risks related to obtaining, maintaining, protecting and defending intellectual property rights. | 2026-Q2 2026-09-09 27 | |
| Ability to maintain the value of beauty and wellness brands in competitive market. | 2026-Q2 2026-09-09 27 | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2026-06-02 (2026-Q1), source 25 | ||
| Sharp decline in first orders during Q1 will negatively impact repeat business throughout the year | = | |
| Illegal distribution and counterfeit versions of products and unauthorized diversion by third parties | = | |
| Potential market saturation and brand health risks in customer acquisition | = | |
| Oddity Tech: first mention in 20-F annual report of 2026-03-17 (FY2025), source 24 | ||
| inaccuracy in third-party data or limited access to third-party data used in AI models | = | |
| loss of ability to use customer or third-party data due to new laws or regulatory restrictions | = | |
| Fraudulent transactions and chargeback rates expose company to payment method restrictions | = | |
| negative publicity regarding ethical business practices transparency or supplier compliance | = | |
| 2026 Credit Facilities subject to several covenants as specified in agreements | = | |
| 2026 Credit Facilities contain Net Debt-to-EBITDA covenant not to exceed 4x; undrawn but could restrict operations if drawn | = | |
| Moody's downgraded Israel credit rating September 2024; Standard & Poor's also downgraded October 2024 | = | |
| $600.0 million exchangeable notes issued June 2025 due 2030 with exchange conditions | = | |
| equity issuances could result in significant dilution of shareholder ownership interests | = | |
| conditional exchange feature of Exchangeable Notes if triggered could adversely affect liquidity | = | |
| may not have sufficient funds to settle exchanges or repurchase Exchangeable Notes upon fundamental change | = | |
| may require additional capital and may not obtain financing on favorable terms | = | |
| SEC Concept Release on June 4 2025 may amend definition; if lost status requires domestic issuer compliance | = | |
| Expansion to multiple jurisdictions increases effective tax rate volatility and audit risk | = | |
| Early March 2026 Hezbollah joined conflict with missile attacks; Israel retaliation ongoing | = | |
| February 2026 preemptive attack on Iran; subsequent missile attacks throughout Israel and region | = | |
| political or social unrest or economic instability in operating locations | = | |
| expansion of distribution center capacity and warehouse management system reliability | = | |
| increased shipping times to and from international markets | = | |
| distribution capacity dependent on timely performance by third-party suppliers and logistics providers | = | |
| Loss of certain single-source suppliers could adversely affect business operations | = | |
| inability to adequately staff distribution centers or higher staffing costs | = | |
| Approximately 17% of 2025 revenue derived from non-U.S. markets with currency exposure | = | |
| workplace safety issues and employment claims for labor law violations | = | |
| compliance with FCPA, Israeli Penal Law, and U.K. Bribery Act by employees and business partners | = | |
| supplier non-compliance with applicable laws could lead to litigation or vendor changes | = | |
| Difficult to enforce U.S. judgments against Israeli officers and directors; Israeli courts may refuse U.S. securities law claims | = | |
| Exclusive forum provision for Securities Act claims may increase litigation costs and discourage shareholder claims | = | |
| Employees may claim remuneration for service inventions despite assignment agreements; potential litigation | = | |
| Israeli law imposes fiduciary duties on shareholders that differ from U.S. corporations; little binding case law available | = | |
| Obligations to disclose or license proprietary code; significant legal expenses defending against allegations | = | |
| Product liability and manufacturing compliance failures trigger recalls and regulatory enforcement | = | |
| Israeli tax considerations may make transactions undesirable; tax deferral contingent on numerous conditions | = | |
| delays and expenses associated with compliance including record keeping, documentation, labeling | = | |
| DHA restrictions and EU Cosmetics Regulation amendments impact product formulation and market access | = | |
| Uyghur Forced Labor Prevention Act creates import bans and supply chain uncertainty | = | |
| difficulties in understanding and complying with local laws, regulations, and customs | = | |
| PCI Standard compliance and payment processor failures risk transaction disruption | = | |
| tariffs, quotas, local content rules, and tax consequences | = | |
| regulations relating to internet seller registration, anti-money laundering, trade sanctions, anti-corruption | = | |
| AI models may prove less accurate than expected due to flawed algorithms or biased data | = | |
| AI models may contain errors, be inaccurate, or fail to analyze facial and hair features correctly | = | |
| website downtime, technical failures, system capacity issues, data breaches, security incidents | = | |
| decline in demand for technology platform due to malfunction or inferior performance | = | |
| Dependence on information technology systems and cloud infrastructure for operations | = | |
| Business model centered on proprietary in-house technology; continued innovation required to maintain competitive advantage | = | |
| increased competition from local providers of similar products | = | |
| Exposure to credit card fraud and online commerce risks | = | |
| May fail or be perceived to fail in corporate citizenship and sustainability goals; standards evolving; criticisms possible | = | |
| Uncertainty regarding sufficiency of cash and cash equivalents to repay indebtedness. | = | |
| Disclosure controls can only provide reasonable assurance; misstatements due to error or fraud may not be detected | = | |
| Controlled company; may rely on Nasdaq exemptions from corporate governance requirements | = | |
| Rely on foreign private issuer exemption from Nasdaq shareholder meeting quorum and independent director rules | = | |
| Risk of passive foreign investment company classification based on income and asset composition; PFIC rules apply if classified | = | |
| Market price of Class A shares volatile; fluctuates based on revenue, results, analyst estimates, competition, litigation | = | |
| New tax laws and regulations may adversely affect business profitability; interpretations may change | = | |
| Active trading market for Class A shares may not be sustained; could impair ability to sell shares or raise capital | = | |
| Operations in multiple jurisdictions with varying regulatory regimes; Brexit created separate U.K. regulatory framework for cosmetics | = | |
| Boycott, divestment and sanctions campaign against Israel; restrictive business policies in some countries | = | |
| Global shipping disruptions due to conflicts affecting Suez Canal and Strait of Hormuz routes. | = | |
| Sustained military conflict Ukraine region likely; supply chain disruptions commodity price volatility energy instability | = | |
| Cost of goods sold fluctuates with raw material costs and transportation rates; future price volatility possible | = | |
| reliance on third parties for computer hardware, software, and product delivery | = | |
| Business dependent on consumer demand for beauty and wellness products and online shopping migration trends | = | |
| need to offer customer services in various languages | = | |
| Intense competition for skilled personnel, particularly engineers and technical staff. | = | |
| liability for online content | = | |
| Israeli law and articles require special procedures for mergers and acquisitions; concentrated voting power delays change of control | = | |
| Trade secrets and know-how difficult to protect; courts less willing to protect in some jurisdictions | = | |
| Climate change legislation creates uncertain compliance costs and operational impacts | = | |
| Compliance with GDPR, CPRA and other data protection regulations | = | |
| E-commerce and internet regulations create uncertain compliance requirements and tax obligations | = | |
| FDA may require warning labels, restrict ingredient use, or initiate recalls if products lack safety substantiation or are improperly labeled | = | |
| Acquisition integration may fail; may not achieve long-term plans; could adversely affect business | = | |
| Market opportunity estimates and forecasts subject to significant uncertainty; business may fail to grow at similar rates | = | |
| varying levels of internet technology adoption and infrastructure | = | |
| Failure in internet or mobile device accessibility could disrupt operations and revenue | = | |
| Dependence on mobile operating systems we do not control; changes could adversely affect user experience | = | |
| rapid technology changes | = | |
| disruptions in internet service or power outages | = | |
| varying business practices and customs related to beauty and wellness products | = | |
| Intense competition from larger multinational companies with greater resources. | = | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2026-02-25 (2025-Q4), source 22 | ||
| Abnormally high new user acquisition costs due to algorithm changes from largest advertising partner; expected to impact Q1 2026 negatively. | = | |
| Reliance on advertising platform algorithms and bidding systems; algorithm changes directly impact user acquisition economics. | = | |
| Loss of suppliers or shortages/disruptions in raw materials or finished products supply. | = | |
| Changes in laws and regulatory requirements applicable to e-commerce, internet regulation, AI-related laws, tax laws, data privacy and security laws. | = | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2025-11-19 (2025-Q3), source 21 | ||
| Concentration of voting power as a result of dual class structure. | = | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2025-06-10 (2025-Q2), source 17 | ||
| Future issuances of Class A or convertible shares could negatively affect market price | FY2025 2026-03-17 24 | |
| Offering subject to market conditions; no assurance timing, size, or completion | = | |
| Oddity Tech: first mention in 20-F annual report of 2025-02-25 (FY2024), source 15 | ||
| U.S. person owning 10% or more may be treated as United States shareholder in CFC; subject to Subpart F income reporting | FY2025 2026-03-17 24 | |
| fluctuations in currency exchange rates and currency control regulations | FY2025 2026-03-17 24 | |
| marketable securities subject to credit, liquidity, market and interest rate risks | FY2025 2026-03-17 24 | |
| legal actions and proceedings including IP infringement, contract breaches, employment, securities matters | FY2025 2026-03-17 24 | |
| Putative class action alleging Securities Act violations in IPO and secondary offering | FY2025 2026-03-17 24 | |
| $20.6 million unrecognized tax benefits subject to examination; Israel open tax years 2021-2025 | FY2025 2026-03-17 24 | |
| FDA and FTC restrictions on marketing claims require substantiation and risk warning letters | FY2025 2026-03-17 24 | |
| subject to federal, state, and international laws on product delays, import limitations, labeling claims | FY2025 2026-03-17 24 | |
| Tax benefits require meeting conditions; programs may be discontinued or requirements unmet; potential refund obligations | FY2025 2026-03-17 24 | |
| Risk that trademarks not adequately protected; may not maintain brand recognition or prevent competitor trademark adoption | FY2025 2026-03-17 24 | |
| Loss of suppliers or disruptions in supply of raw materials or finished products | 2026-Q1 2026-06-02 25 | |
| Ransomware attacks from criminal and state actors threaten operational continuity | FY2025 2026-03-17 24 | |
| Revenue expectations recently fell below analyst estimates; share price declined significantly; risk of further downgrade | FY2025 2026-03-17 24 | |
| No intention to pay dividends in foreseeable future; shareholders depend on price appreciation | FY2025 2026-03-17 24 | |
| Quarterly results may fluctuate; may not meet guidance or analyst expectations; stock price may decline | FY2025 2026-03-17 24 | |
| changes in applicable federal, state, and international regulations | FY2025 2026-03-17 24 | |
| Changes to U.S. GAAP principles or interpretations could significantly impact reported financial results | FY2025 2026-03-17 24 | |
| Intellectual property rights may not receive same protection in foreign countries; enforcement mechanisms inadequate in some jurisdictions | FY2025 2026-03-17 24 | |
| Beauty and wellness industry highly competitive with numerous global and independent brands offering similar products | FY2025 2026-03-17 24 | |
| Competition in beauty and wellness industries; ability to maintain brand value and market share at risk. | 2025-Q4 2026-02-25 22 | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2024-11-06 (2024-Q3), source 12 | ||
| Conditions in Israel and Middle East geopolitical conflict affecting operations | 2026-Q1 2026-06-02 25 | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2024-05-07 (2024-Q1), source 8 | ||
| Class B shares have 10 votes per share; CEO holds 73.3% voting power; concentrates control and limits shareholder influence | FY2025 2026-03-17 24 | |
| Failure to accurately forecast customer demand could result in excess inventory or stockouts. | FY2025 2026-03-17 24 | |
| Oddity Tech: first mention in 20-F annual report of 2024-03-06 (FY2023), source 7 | ||
| Largest advertising partner account dislocation causing severe CPA increases up to 2x expected levels | 2026-Q1 2026-06-02 25 | |
| debt financing could involve restrictive covenants limiting operations and financial flexibility | FY2025 2026-03-17 24 | |
| failure to offer high quality customer support or achieve high customer satisfaction | FY2025 2026-03-17 24 | |
| Sourced from diversified supplier base but rely on third-party contract manufacturers and suppliers for inventory procurement | FY2025 2026-03-17 24 | |
| Dependence on third-party shipping providers; port congestion, labor disputes, and route disruptions pose risks. | FY2025 2026-03-17 24 | |
| Brand value vulnerable to negative publicity through social media; isolated incidents can erode customer trust. | FY2025 2026-03-17 24 | |
| Substantial costs and diversion of management for IP enforcement and patent litigation | FY2025 2026-03-17 24 | |
| Putative class action lawsuit Peters v. Oddity Tech Ltd. filed March 12, 2026 alleging securities violations | FY2025 2026-03-17 24 | |
| FCPA UK Bribery Act and Israeli Anti-Corruption Laws require global compliance | FY2025 2026-03-17 24 | |
| Collect and process personal data subject to GDPR, CCPA, CPRA and other data privacy regulations; data breaches could result in significant liability | FY2025 2026-03-17 24 | |
| Competitors may infringe patents or reverse-engineer proprietary software | FY2025 2026-03-17 24 | |
| difficulty obtaining, maintaining, protecting, and enforcing intellectual property rights abroad | FY2025 2026-03-17 24 | |
| product cost increases or selling price decreases could reduce sales and profitability | FY2025 2026-03-17 24 | |
| Insurance coverage may not be sufficient or available for all types of losses; war and force majeure typically excluded | FY2025 2026-03-17 24 | |
| Historical rapid growth may not be sustainable; challenges expected in 2026 from customer acquisition issues. | FY2025 2026-03-17 24 | |
| Variable interest rate exposure on potential future credit facility borrowings | FY2025 2026-03-17 24 | |
| Operating metrics subject to measurement challenges; inaccuracies could undermine investor confidence | FY2025 2026-03-17 24 | |
| Increased operating expenses may exceed revenue growth; maintenance of profitability uncertain. | FY2025 2026-03-17 24 | |
| Increased costs for compliance with SEC Sarbanes-Oxley Dodd-Frank Exchange Act and Nasdaq rules | FY2025 2026-03-17 24 | |
| OECD Pillar Two minimum tax and international tax reform increase tax obligations | FY2025 2026-03-17 24 | |
| Only 18% of net revenue from outside United States; international penetration below global competitors | FY2025 2026-03-17 24 | |
| Tariffs quotas and trade embargoes affect product sourcing and international expansion | FY2025 2026-03-17 24 | |
| Exposure to foreign currency fluctuations; operations in multiple countries. | 2025-Q4 2026-02-25 22 | |
| Natural disasters climate change earthquakes wildfires hurricanes could disrupt operations supply chain consumer spending | FY2025 2026-03-17 24 | |
| Non-compete agreements may not be enforceable under Israeli law; former employees may benefit competition | FY2025 2026-03-17 24 | |
| Critical accounting policy estimates may be based on incorrect assumptions; results may fall below expectations | FY2025 2026-03-17 24 | |
| Disclosure controls and internal control over financial reporting may become inadequate; material weaknesses possible | FY2025 2026-03-17 24 | |
| Foreign private issuer status exempts from certain U.S. proxy and reporting rules; may lose status if conditions change | FY2025 2026-03-17 24 | |
| Oddity Tech: first mention in 6-K-EX99.1 earnings release of 2023-10-02 (2023-Q3), source 4 | ||
| Reliance on third-party service providers with limited control over their cybersecurity practices | FY2025 2026-03-17 24 | |
| EU AI Act and evolving AI regulations increase compliance costs and restrict AI deployment | FY2025 2026-03-17 24 | |
| product returns could increase due to consumer confidence changes or competitive pressures | FY2025 2026-03-17 24 | |
| Dependency on repeat purchases from engaged customers; satisfaction with products and service critical to revenue. | FY2025 2026-03-17 24 | |
| US and international tariffs increase product costs and supply chain complexity | FY2025 2026-03-17 24 | |
| Fluctuating costs of raw materials could increase cost of goods sold. | FY2025 2026-03-17 24 | |
| Subject to FDA, FTC and various EU regulations governing ingredients, labeling, advertising, safety and manufacturing of cosmetic and dietary supplement products | FY2025 2026-03-17 24 | |
| Inability to anticipate consumer preferences and market trends could harm competitive position. | FY2025 2026-03-17 24 | |
| Failure to successfully develop and market new brands or products could impair growth. | FY2025 2026-03-17 24 | |
Oddity Tech Reported KPIs (as disclosed) (194)
Figures Oddity Tech discloses itself in addition to the standard financials, such as order intake, recurring revenue or unit counts, as reported and with no calculation of our own. NadirAlpha methodology
| KPI | Value / change | Source |
|---|---|---|
| Oddity Tech, published 2026-09-09, period 2026-Q2 | ||
| spoiledchild growth Q2 | double-digit | 27 |
| spoiledchild FY2026 guidance | at least 35% compared to 2025 and approach $350 million of net revenue | 27 |
| Gross margin | 68.7% | 27 |
| Gross margin | 72.3% | 27 |
| Cash and investments | $561 million | 27 |
| Aggregate credit facilities | $350 million | 27 |
| Oddity Tech, published 2026-06-02, period 2026-Q1 | ||
| Share repurchase amount | approximately $82.3 million | 25 |
| Remaining share buyback authorization | approximately $167.3 million | 25 |
| Other revenue percent | 2% | 25 |
| Online direct-to-consumer revenue percent | 98% | 25 |
| IL MAKIAGE CPA improvement May | -28% | 25 |
| Gross margin prior year | 74.9% | 25 |
| Gross margin | 69.7% | 25 |
| Class A ordinary shares repurchased | approximately 6.1 million | 25 |
| Class A ordinary shares outstanding reduction | approximately 10.6% | 25 |
| Cash, cash equivalents and investments | $667.4 million | 25 |
| Aggregate credit facilities | $350 million | 25 |
| Oddity Tech, published 2026-03-17, period FY2025 | ||
| Weighted avg. grant date fair value, options | $58.18 | 24 |
| Weighted avg. grant date fair value, options | $34.97 | 24 |
| Weighted avg. grant date fair value, options | $8.59 | 24 |
| Weighted avg. fair value, RSUs/PSUs vested | $37.77 | 24 |
| Weighted avg. fair value, RSUs/PSUs granted | $52.79 | 24 |
| Unrecognized tax benefits, end | $ 20,567 | 24 |
| Unrecognized tax benefits, beginning | $ 12,519 | 24 |
| Unrecognized compensation costs, RSUs | $45,476 | 24 |
| Unrecognized compensation costs, options | $12,810 | 24 |
| Undistributed earnings, foreign subsidiaries | approximately $47,000 | 24 |
| Total long-lived assets | $ 33,175 | 24 |
| Total long-lived assets | $ 33,384 | 24 |
| Total intrinsic value, options exercised | $57,236 | 24 |
| Exchangeable notes, fair value | $521,220 | 24 |
| Exchangeable notes, exchange rate | 10.8655 | 24 |
| Exchangeable notes, exchange price | $92.03 | 24 |
| ESPP shares reserved | 2,257,949 | 24 |
| Users | approximately 68 million | 24 |
| Return rate | 11.0% | 24 |
| Online direct-to-consumer revenue % | 97% | 24 |
| Net income margin | 13.7% | 24 |
| Maximum dollar value of Class A ordinary shares yet to be purchased 2026 Buyback Plan | 102,716 | 24 |
| International revenue % | 18% | 24 |
| Gross margin | 72.7% | 24 |
| Adjusted EBITDA margin | 20.2% | 24 |
| 2023 plan shares available for grant | 8,371,647 | 24 |
| Oddity Tech, published 2026-02-25, period 2025-Q4 | ||
| Users served | approximately 68 million | 22 |
| Credit facilities | $350 million | 22 |
| Cash, equivalents and investments | $776 million | 22 |
| Oddity Tech, published 2025-11-19, period 2025-Q3 | ||
| Undrawn credit facilities | $200 million | 21 |
| Total cash and investments | 792,596 | 21 |
| Short-term deposits and restricted cash | 26,712 | 21 |
| Marketable securities | 173,889 | 21 |
| Cash and cash equivalents | 591,995 | 21 |
| Oddity Tech, published 2025-08-04, period 2025-Q2 | ||
| Undrawn credit facilities | $200 million | 18 |
| Net income margin | 20.4% | 18 |
| Gross margin | 72.3% | 18 |
| Cash and cash equivalents | $815 million | 18 |
| Adjusted net income margin | 23.7% | 18 |
| Adjusted EBITDA margin | 28.8% | 18 |
| Oddity Tech, published 2025-06-10, period 2025-Q2 | ||
| Undrawn credit line | $200 million | 17 |
| Cash on hand | $257 million | 17 |
| Oddity Tech, published 2025-04-29, period 2025-Q1 | ||
| Online direct-to-consumer revenue % | 97% | 16 |
| Online direct-to-consumer revenue | 261,053 | 16 |
| Cash and investments | 256,770 | 16 |
| Oddity Tech, published 2025-02-25, period FY2024 | ||
| Users | approximately 60 million | 15 |
| Total shareholders equity | 282,304 | 15 |
| Total shareholders equity | 283,107 | 15 |
| Total current liabilities | 124,802 | 15 |
| Total current liabilities | 109,312 | 15 |
| Total current assets | 223,369 | 15 |
| Total current assets | 223,812 | 15 |
| Total assets | 438,882 | 15 |
| Total assets | 404,906 | 15 |
| Short-term deposits | 48,000 | 15 |
| Short-term deposits | 78,000 | 15 |
| Property, plant and equipment, net | 9,817 | 15 |
| Property, plant and equipment, net | 9,245 | 15 |
| Operating income | 115,600 | 15 |
| Net revenue | 647,040 | 15 |
| Net income margin | 15.7% | 15 |
| Net income | 101,491 | 15 |
| Marketable securities, short-term | 1,880 | 15 |
| Marketable securities, short-term | 1,108 | 15 |
| Marketable securities, long-term | 68,831 | 15 |
| Marketable securities, long-term | 50,507 | 15 |
| gross profit | 468,322 | 15 |
| gross margin | 72.4% | 15 |
| cash from operations | 137,764 | 15 |
| cash and equivalents | 169,100 | 15 |
| cash and cash equivalents | 50,340 | 15 |
| cash and cash equivalents | 36,538 | 15 |
| advertising costs | 164,370 | 15 |
| advertising costs | 125,625 | 15 |
| advertising costs | 92,048 | 15 |
| adjusted EBITDA margin | 23.3% | 15 |
| weighted average grant date fair value of options granted | 34.97 | 15 |
| weighted average fair value at grant date of RSUs and PSUs granted | 33.14 | 15 |
| valuation allowance | 839 | 15 |
| unrecognized compensation costs related to non-vested options | 29,348 | 15 |
| unrecognized compensation costs related to RSUs | 32,390 | 15 |
| undistributed earnings of foreign subsidiaries | 37,278 | 15 |
| total shares repurchased average price | $40.84 | 15 |
| total shares repurchased | 3,606,419 | 15 |
| shares repurchased under program | 1,253,534 | 15 |
| share repurchase Sep 2024 quantity | 301,892 | 15 |
| Share repurchase Sep 2024 price | $34.74 | 15 |
| Share repurchase Nov 2024 quantity | 2,352,885 | 15 |
| Share repurchase Nov 2024 price | $42.50 | 15 |
| Share repurchase Jun 2024 quantity | 250,000 | 15 |
| Share repurchase Jun 2024 price | $41.43 | 15 |
| Share repurchase Aug 2024 quantity | 701,642 | 15 |
| Share repurchase Aug 2024 price | $37.68 | 15 |
| Revela restricted Class A shares issued | 612,256 | 15 |
| Revela cash paid | $32.5 million | 15 |
| Revela acquisition price | $67.4 million | 15 |
| Revela Class A shares issued | 701,591 | 15 |
| Maximum dollar value remaining | $102,716 | 15 |
| Long-lived assets (United States) | 14,961 | 15 |
| Long-lived assets (Israel) | 18,423 | 15 |
| IPO net proceeds | approximately $50.3 million | 15 |
| Diluted EPS | $ 1.64 | 15 |
| Diluted EPS | $ 1.00 | 15 |
| Diluted EPS | $ 0.39 | 15 |
| Class A Ordinary shares reserved and available for grant under 2023 Plan | 4,307,070 | 15 |
| Buyback Plan total authorization | $150 million | 15 |
| Buyback Plan expiration date | June 30, 2027 | 15 |
| Basic EPS | $ 1.77 | 15 |
| Basic EPS | $ 1.06 | 15 |
| Basic EPS | $ 0.41 | 15 |
| Oddity Tech, published 2025-02-25, period 2024-Q4 | ||
| Shares repurchased | 2.35 million | 14 |
| Share repurchases | 147,283 | 14 |
| Outstanding debt | 0 | 14 |
| Cash and investments | 169,058 | 14 |
| Oddity Tech, published 2024-11-06, period 2024-Q3 | ||
| Total cash and investments | 248,233 | 12 |
| Short-term deposits and restricted cash | 57,323 | 12 |
| Outstanding debt | zero | 12 |
| Net operating cash flow | 122 million | 12 |
| Net operating cash flow | 121,599 | 12 |
| Marketable securities | 104,961 | 12 |
| Cash and cash equivalents | 85,949 | 12 |
| Oddity Tech, published 2024-08-07, period 2024-Q2 | ||
| Outstanding debt | zero | 10 |
| Net revenue | $193 million | 10 |
| Net income margin | 23.6% | 10 |
| Gross margin | 72.2% | 10 |
| Diluted EPS | $0.73 | 10 |
| Cash and cash equivalents | $268 million | 10 |
| Adjusted net income margin | 26.5% | 10 |
| Adjusted EBITDA margin | 32.3% | 10 |
| Oddity Tech, published 2024-06-07, period 2024-Q2 | ||
| Undrawn credit facility | $100 million | 9 |
| Financial debt | zero | 9 |
| Cash and investments | over $250 million | 9 |
| Oddity Tech, published 2024-05-07, period 2024-Q1 | ||
| Outstanding debt | zero | 8 |
| Cash and investments | $252 million | 8 |
| Oddity Tech, published 2024-03-06, period FY2023 | ||
| Website and software development costs | 4,585 | 7 |
| Unrecognized compensation costs, share-based | 50,789 | 7 |
| Unrecognized compensation costs, RSUs | 27,966 | 7 |
| Unique users (million) | 50 | 7 |
| Unique data points (billion) | 2 | 7 |
| Undistributed earnings, foreign subsidiaries | 18,116 | 7 |
| Uncertain tax positions | 4,228 | 7 |
| severance expenses | 893 | 7 |
| Oran Holtzman shares sold at IPO | 7,097,696 | 7 |
| options outstanding 2020 plan Dec 31 | 11,826,547 | 7 |
| net income margin pct | 6.7 | 7 |
| net income margin pct | 6.3 | 7 |
| net income margin pct | 11.5 | 7 |
| LCGP3 shares sold at IPO | 5,068,969 | 7 |
| IPO date | July 19, 2023 | 7 |
| IPO class A shares issued | 1,754,385 | 7 |
| gross margin pct | 67.2 | 7 |
| gross margin pct | 68.8 | 7 |
| gross margin pct | 70.4 | 7 |
| class B ordinary shares outstanding Dec 31 | 11,547,000 | 7 |
| class A ordinary shares outstanding Dec 31 | 45,319,675 | 7 |
| Capex | 2.1 | 7 |
| Capex | 2.3 | 7 |
| Capex | 2.4 | 7 |
| advertising costs | 125,625 | 7 |
| adjusted EBITDA margin pct | 12.2 | 7 |
| adjusted EBITDA margin pct | 12.0 | 7 |
| Adjusted EBITDA Margin % | 21.1 | 7 |
| Restricted Cash | 2,228 | 7 |
| Order Billings | 595,772 | 7 |
| Net Income Margin | 11.5 | 7 |
| Adjusted EBITDA margin | 21.1 | 7 |
| Oddity Tech, published 2024-03-05, period 2023-Q4 | ||
| Platform Users | 50 million | 6 |
| Cash and Investments | 168 million | 6 |
| Oddity Tech, published 2023-11-07, period 2023-Q3 | ||
| Free Cash Flow YTD | $78 million | 5 |
| Cash, Restricted Cash and Short-Term Deposits | $164 million | 5 |
| Oddity Tech, published 2023-08-09, period 2023-Q2 | ||
| Users | over 40 million | 1 |
| Net Income Margin | 19.8% | 1 |
| Gross Margin | 70.6% | 1 |
| Gross Margin | 68.2% | 1 |
| Cash and cash equivalents | 106.7 million | 1 |
| Adjusted Net Income Margin | 21.3% | 1 |
| Adjusted EBITDA Margin | 27.6% | 1 |
Oddity Tech Development
A condensed summary of Oddity Tech per reporting period as running text: what changed operationally, which drivers management names, how earnings and cash flow developed. NadirAlpha methodology
FY2026: Oddity Tech
ODDITY Tech reported net revenue of 197.9 million in Q1 2026 and 180.5 million in Q2 2026, with year-over-year declines of 26% 25 and 25% 27 respectively, driven by customer acquisition cost dislocation related to IL MAKIAGE's largest advertising partner. Gross margin compressed in both quarters, falling to 69.7% in Q1 25 and 68.7% in Q2 27, reflecting product and brand mix shifts, lower average order values, and remediation costs. Net results were a loss of 21.4 million in Q1 25, recovering to a profit of 12.9 million in Q2 27. Newer brands SpoiledChild and the recently launched METHODIQ showed growth momentum, with METHODIQ expected to deliver first-year net revenue ahead of SpoiledChild's inaugural year 27. For full year 2026, ODDITY guided for net revenue to decline approximately 19% year-over-year and adjusted EBITDA between $30 million and $32 million 27.
FY2025: Oddity Tech
ODDITY delivered full-year 2025 net revenue of 809.8 million, up 25% year-over-year, driven by higher order volume across its direct-to-consumer beauty and wellness brands 24. Oddity Tech reported net income of 110.7 million, up 9.1% from the prior year, while adjusted EBITDA grew 8.5% to $163 million 24. During fiscal 2025, ODDITY launched METHODIQ, its third brand aimed at transforming medical care through precise treatments and technology, in the fourth quarter 24. In June 2025, the company issued $600 million aggregate principal of 0% Exchangeable Senior Notes due 2030, with proceeds intended for general corporate purposes and potential future strategic M&A 24. Heading into 2026, ODDITY disclosed a significant dislocation in customer acquisition costs driven by algorithmic changes at its largest advertising partner, with first-quarter 2026 revenue expected to decline approximately 30% year-over-year 22.
FY2024: Oddity Tech
ODDITY Tech delivered full-year 2024 net revenue of 647 million, up 27% year-over-year, and exceeded its financial guidance across every metric in each quarter of the year 14. Gross margin expanded 200 basis points to 72.4% in 2024 driven by supply chain efficiencies 15, and adjusted EBITDA reached $150 million at a 23.3% margin, representing 40% year-over-year growth 14. Net income for the full year was 101.5 million, compared to $58.5 million in 2023 15, with free cash flow of 134.5 million 14. ODDITY repurchased $147 million of shares in 2024, including approximately 2.35 million shares from LCGP3 at $42.50 per share in November 2024 15, and entered 2025 with guidance for net revenue of $776-785 million, representing approximately 20% growth at the midpoint 14.
FY2023: Oddity Tech
ODDITY generated full year net revenue of 508.7 million in 2023, representing 56.7% year-over-year growth driven by 40.2% order growth and an improvement in return rates from 14.8% to 12.0% 7. Full year net income was 58.5 million with diluted EPS of 1.00 and adjusted EPS of 1.31 24. Oddity Tech completed its initial public offering on Nasdaq on July 19, 2023, and acquired Revela Inc. on May 12, 2023, establishing ODDITY LABS as an AI-based molecule discovery platform for beauty and wellness products 7. Gross margin expanded to 70.4% from 67.2% in the prior year, largely driven by supply chain efficiencies; full year adjusted EBITDA reached $107.3 million at a 21% margin, and free cash flow was 85.4 million 7 6. ODDITY's platform reached approximately 50 million unique users by December 31, 2023, with no outstanding debt on the balance sheet and two new brand launches planned for 2025 6.
Glossary
- Revenue: Revenue from contracts with customers, net of sales deductions, as the company itself reports it; not total output, gross revenue, GMV or order intake.
- Op. income: The operating line of the income statement; EBIT only as a marked fallback, never pre-tax or ordinary income.
- EBITDA (adj.): Adjusted EBITDA, verbatim and company-defined (non-GAAP), never derived.
- Net income: Net income attributable to the shareholders of the parent, after discontinued operations; not the result including minority interests, not comprehensive income.
- EPS: Diluted earnings per share attributable to the shareholders of the parent; a printed figure always beats a calculated one, calculated values are marked.
- EPS adj.: Adjusted earnings per share, verbatim and company-defined (non-GAAP).
- FCF: Free cash flow = operating cash flow minus capital expenditure on property, plant and equipment; the company's own free cash flow figure is shown separately.
- OCF: Cash flow from operating activities as reported; IFRS companies may show interest paid in financing cash flow, so the figure is not always comparable.
- Cash: Cash and cash equivalents, without securities unless the company reports them as part of the position.
- Net Debt: Net debt = financial debt excluding lease liabilities minus cash at the same reporting date; the company's own net position may differ.
- *: derived, the formula is in the hover
- ≈: calculated, approximation
- ~: uncertain; the value stays visible, verdicts do not use it
- °: repaired by a targeted query against the document, or curated with documentary evidence
- EBIT: EBIT as a fallback: the income statement carries no operating line
- basic: basic earnings per share as a fallback when diluted is missing
Sources: quarterly reports, annual reports and investor relations documents
27 sources on Oddity Tech since 2023; the superscript numbers in the chapters refer to these rows, older documents are in the expandable part. NadirAlpha methodology
Oddity Tech Stock FAQ
Is there a management forecast (guidance) for FY2026?
Yes. Management has issued targets for FY2026, including EBITDA (adjusted). The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.
Where can I find the official investor relations documents of Oddity Tech?
NadirAlpha links all 27 original filings used (SEC filings) in the sources chapter: earnings release, annual report, each with type, publication date and a direct link; every figure in the report carries a source number.